(CercleFinance.com) – Lumibird announces the launch by Lumibird Medical of C.DIAG, a new generation dry eye diagnosis support platform integrating AI. This launch, on a European scale, follows the CE marking certified by LNE-GMED on April 30.
This product integrates the C.SUITE offering which covers the diagnosis, treatment and education of patients about dry eye and positions Lumibird Medical as a unique player in a market estimated at $6.4 billion in 2024.
‘In the global dry eye market, the share dedicated to medical devices is experiencing the strongest growth with an estimated increase of more than 20% by 2026’ underlines Delphine Southon, product manager of the dry eye range.